A subarachnoid stroke is a type of stroke that occurs when there is bleeding in the area between the brain and spinal cord. This type of stroke is caused by bleeding from an intracranial aneurysm, an abnormal bulge in one of the arteries that supply the brain, or a rupture of a saccular aneurysm, a type of aneurysm that is shaped like a berry. Subarachnoid strokes can also be caused by arteriovenous malformations (AVMs) that occur in the brain, which are an abnormal connection between veins and arteries. The immediate symptoms of a subarachnoid stroke include sudden severe headache, coma, difficulty breathing, nausea, vomiting, and a decrease in blood pressure. Other symptoms may include confusion, vision changes, and speech difficulties. While these symptoms can be extremely serious, the good news is that most people who experience a subarachnoid stroke survive and can go on to make a full recovery. When a subarachnoid stroke is suspected, medical professionals will usually perform a CT scan or an MRI of the head to confirm the diagnosis. Following the diagnosis, some people may require endovascular coiling, a procedure in which small coils are inserted into the aneurysm to stop the bleeding. In some cases, a craniotomy may be necessary to control and repair the aneurysm. Other treatments include medications to control symptoms and reduce the risk of a second stroke and lifestyle modifications to minimize the risk of further problems. In most cases, a subarachnoid stroke can be managed successfully and the patient can make a full recovery. However, it is still important to take the necessary steps to minimize the risk of a future stroke, including avoiding smoking and heavy alcohol use, exercising regularly, and eating a healthy diet.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States